Enavate Sciences GP

Latest statistics and disclosures from Enavate Sciences GP's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ZBIO, IMNM, SION, UPB, CMPX, and represent 89.84% of Enavate Sciences GP's stock portfolio.
  • Added to shares of these 1 stock: ZBIO (+$5.7M).
  • Reduced shares in these 1 stock: CAMP.
  • Enavate Sciences GP was a net buyer of stock by $1.1M.
  • Enavate Sciences GP has $507M in assets under management (AUM), dropping by 54.73%.
  • Central Index Key (CIK): 0001953107

Tip: Access up to 7 years of quarterly data

Positions held by Enavate Sciences GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Enavate Sciences GP

Enavate Sciences GP holds 7 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Zenas Biopharma (ZBIO) 28.1 $142M +4% 3.9M 36.31
 View chart
Immunome (IMNM) 20.2 $102M 4.8M 21.48
 View chart
Sionna Therapeutics (SION) 20.1 $102M 2.5M 41.14
 View chart
Upstream Bio (UPB) 13.2 $67M 2.5M 27.15
 View chart
Compass Therapeutics (CMPX) 8.3 $42M 7.8M 5.37
 View chart
Bridgebio Oncology Therapeut Com New (BBOT) 6.5 $33M 2.6M 12.52
 View chart
Camp4 Therapeutics Corp (CAMP) 3.7 $19M -19% 3.0M 6.13
 View chart

Past Filings by Enavate Sciences GP

SEC 13F filings are viewable for Enavate Sciences GP going back to 2025